Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$32.5M
Prescriptions
724
$44,917.40 per claim
Patients
129
115 prescribers
Total spending, 2024
$32.5M
$252,094.53 per patient
Medicare prescription drug plans paid $32.5M for Fabhalta in 2024, for 724 prescriptions and refills to 129 patients. The average cost per claim was $44,917.40.
California had the highest Medicare cost for Fabhalta in 2024: $4.9M for 110 claims, followed by Ohio ($4.5M).
Jaroslaw P Maciejewski, hematology-oncology in Cleveland, OH, had the highest Medicare cost for Fabhalta in 2024: 56 claims costing $2.6M.
Fabhalta is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jaroslaw P Maciejewski Cleveland, OH | Hematology-Oncology | 56 | Under 11 | $2.6M |
| Laurie B Matt-Amaral Akron, OH | Medical Oncology | 20 | Under 11 | $882K |
| Joseph H Antin |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2024 | 115 | 724 | 129 | $32.5M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 724 |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematopoietic Cell Transplantation and Cellular Therapy |
| 18 |
| Under 11 |
| $827K |
| Eduardo Fernandez Hernandez Newport Beach, CA | Hematology | 17 | Under 11 | $770K |
| Thomas G Deloughery Portland, OR | Hematology-Oncology | 17 | Under 11 | $759K |
| Abdulraheem Yacoub Westwood, KS | Hematology-Oncology | 15 | Under 11 | $662K |
| Srinivasa R Sanikommu Charlotte, NC | Hematology-Oncology | 12 | Under 11 | $540K |
| Carolyn Carrera Ypsilanti, MI | Hematology-Oncology | 12 | Under 11 | $539K |
| James Rossetti Pittsburgh, PA | Hematology | 11 | Under 11 | $504K |
| Luis G Sepulveda-Maldonado Ponce, PR | Hematology | 11 | Under 11 | $503K |
| Ronald L Sham Rochester, NY | Hematology-Oncology | 11 | Under 11 | $498K |
| Jose M Tongol Albany, GA | Hematology-Oncology | 11 | Under 11 | $497K |
| David Dingli Rochester, MN | Hematology | 11 | Under 11 | $494K |
| Eloy Roman Miami Lakes, FL | Hematology-Oncology | 11 | Under 11 | $489K |
| Zahra Pakbaz Orange, CA | Hematology-Oncology | 11 | Under 11 | $481K |
| Molly M Gallogly Cleveland, OH | Hematology-Oncology | 11 | Under 11 | $477K |
| $32.5M |